Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 7,670

Document Document Title
WO/2013/035899A1
The present invention relates to a method for preparing 5-hydroxy-1,3-dioxane (α, α'-isomer of glycerol formal) which is very suitable as a raw material for branched glycerol, and more particularly, to a method for preparing 5-hydroxy-...  
WO/2013/010882A3
The compounds of formula (I) in which L represents a radical of formula (a) or (b), and A1, B1 or A2 and B2 are defined as in claim 1, can be used as herbicides for combating pest plants or as plant growth regulators. The compounds can b...  
WO/2013/010488A1
The present invention relates to the field of pharmaceutical chemistry, specifically relates to a statin intermediate having formula (I) and preparation thereof. The advantages of the method used to prepare the chiral sulfone intermediat...  
WO/2013/004296A1
The present invention relates to a method for making a polymer wherein during ring opening polymerisation is incorporated into the polymer chain at least one cyclic (alkyl) carbonate monomer having the formula (1) wherein Y is optional a...  
WO/2012/176856A2
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...  
WO/2012/176792A1
The present invention relates to a method and a pharmaceutical composition for suppressing immunity, in each of wherein a fatty acid derivative represented by general formula (I) is utilized. The present invention also relates to a metho...  
WO/2012/175650A1
The present invention relates to a method for the hydrothermolysis of a mono- and/or oligosaccharide-comprising composition which in addition comprises at least one monoalkyl and/or dialkyl ether of a polyalkylene glycol, and also relate...  
WO/2012/177357A9
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...  
WO/2012/177357A1
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...  
WO/2012/169559A1
In order to provide a novel azole derivative, the azole derivative of the present invention is an azole derivative represented by general formula (V'). (In the formula, each of R6 and R7 independently represents a hydrogen atom, an alkyl...  
WO/2012/158107A1
Linear or cyclic carbonates as potential monomers for isocyanate-free polyurethanes and polycarbonates were prepared from polyols and dialkylcarbonatesor diphenyl carbonates. This invention was developed to produce linear or cyclic carbo...  
WO/2012/153950A2
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/153950A3
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/136568A1
The invention relates to a method for the removal of the cyclic diester of a 2-hydroxy alkanoic acid from a vapor containing said diester, wherein the vapor is contacted with an aqueous solution so that the diester dissolves in said solu...  
WO/2012/138494A1
A process for making a 2-nitro-1-ethanol derivative of formula III: wherein R3 is as described herein is provided. Novel 2-nitro-1-ethanol derivatives provided.  
WO/2012/138254A3
The invention relates to medicine and pharmacology. The novel 4,4'-biphenylamide derivatives are pharmacologically active and can be used as new effective allosteric modulators of АМРА receptors for treating Alzheimer's, Parkinson's ...  
WO/2012/130919A1
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoate from Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(B...  
WO/2012/130920A1
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoatefrom Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(BH...  
WO/2012/133861A1
An amide compound represented by the formula (I): [wherein, R1, R2, R3, R4, R5, R6, R7, R8, X, W, r, n and Y are as defined in the description] has an excellent control effect on harmful arthropods.  
WO/2012/129452A3
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452A2
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452A8
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/125598A1
The present invention relates to compounds of formula (I): wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder....  
WO/2012/118196A1
Provided is a method for concentrating an aqueous solution that contains at least 3-hydroxy-2,2-dimethylpropanal and/or a dimer thereof. The concentration method comprises a step wherein at least one substance selected from the group con...  
WO/2012/114347A1
Disclosed herein is a compound of formula (A), its salts, enantiomers, and diastereomers thereof; wherein, Rl and R2 can be (C1-C6) alkyl groups, a phenyl group, a (C5-C7) cycloalkyl groups; X and Y individually selected from H, -N02, -N...  
WO/2012/116250A1
The invention generally relates to functional polymers and hydrogels. More particularly, the invention provides versatile monomers and polymers with well-defined functionalities, e.g., polycarbonates and poly(ester-carbonates), compositi...  
WO/2012/110118A1
Disclosed is a method to prepare a polylactic acid comprising the steps of: performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW g...  
WO/2012/110117A1
Disclosed is a method to prepare a polylactic acid comprising the steps of performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW gr...  
WO/2012/107158A1
The invention relates to specific [1,3]-dioxan-5-one compounds, to a process for preparation thereof and to the use thereof as dyes or as fluorescent emitters for organic electroluminescent devices (OLEDs) or for organic light-emitting e...  
WO/2012/104659A1
A compound of Formula (I), and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: wherein R1 is independently selected from F, CI, Br, CN, NH2, OH, CHO, COOH, oxo, C1-4al...  
WO/2012/100809A1
The present invention relates to liquid-crystalline compounds having an O-heterocyclic ring, three partly fluorinated benzene rings and a -CF2O- bridge between the rings. The invention also relates to liquid-crystalline media produced th...  
WO/2012/103279A3
The invention features methods and compositions for the synthesis of multimerizing agents. An exemplary method for producing AP20187 may comprise: (a) coupling 2-N,Ndimethylaminomethyl-1,3-diaminopropane with AP20792 to produce the dimer...  
WO/2012/096934A3
Methods for preventing or treating retroviral infection, such as human immunodeficiency virus, in vivo utilize transcriptional inhibitory compounds. These include cortistatin A and analogs of the cortistatin family.  
WO/2012/065116A2
Disclosed herein is a polyhydroxy ketal adduct obtained by forming an ester between of a hydrocarbon polyol and at least 1.5 equivalents of a ketocarboxy to produce an intermediate ketocarboxylic ester. The intermediate polyketocarboxyli...  
WO/2012/065116A3
Disclosed herein is a polyhydroxy ketal adduct obtained by forming an ester between of a hydrocarbon polyol and at least 1.5 equivalents of a ketocarboxy to produce an intermediate ketocarboxylic ester. The intermediate polyketocarboxyli...  
WO/2012/059436A2
The invention relates to novel compounds of formula (I), in which R1, R2, R3, R4, R5, Y, Q and G are defined as indicated above, to several methods and intermediate products for the production thereof and use thereof as herbicides and/or...  
WO/2012/045734A1
The present invention relates to phenyl diamides according to the general formula (1) and their use as a medicament and a pharmaceutical preparation comprising as an active ingredient a phenyl diamide according to the general formula (1)...  
WO/2012/036693A8
The present invention involves a new synthesis route for the formation of lactylates. The method comprises reacting a dilactide with a compound comprising a hydroxy group. This reaction is preferably carried out in the presence of a cati...  
WO/2012/034958A1
The invention relates to compounds of general formula (3) wherein R4 is allyl, 2-butyl, cyclohexyl, 3-methyl-2-butyl or 4-methyl-2-pentyl, a method for the preparation of compounds of general formula (3) and their use in the preparation ...  
WO/2012/036693A1
The present invention involves a new synthesis route for the formation of lactylates. The method comprises reacting a dilactide with a compound comprising a hydroxy group. This reaction is preferably carried out in the presence of a cati...  
WO/2012/035123A1
Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system.  
WO/2012/031933A2
A method is described in which hydroxyacetals or hydroxyacetal mixtures are used for catalytic C-O-C linking reactions to form ethers, especially by telomerizing diene systems, wherein palladium-(0) complexes are used as catalysts, carbo...  
WO/2012/031933A3
A method is described in which hydroxyacetals or hydroxyacetal mixtures are used for catalytic C-O-C linking reactions to form ethers, especially by telomerizing diene systems, wherein palladium-(0) complexes are used as catalysts, carbo...  
WO/2012/032035A1
The invention relates to salts of acids with 2-propyl esters of general formula (2) The invention also relates to a method for the preparation of salts of acids with compounds of general formula (2) and to the use thereof in the preparat...  
WO/2012/029942A1
Provided is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A represents a C6-10 arylene group or the like; R1a, R1b and R1c each independently represents a hydrogen atom, a halogen ...  
WO/2012/023584A1
Provided are a composition derived from ascorbic acid, a method for preparing the composition, and a cosmetic material having the composition mixed therein. The composition derived from ascorbic acid comprises a reaction product obtained...  
WO/2012/017166A3
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/017242A1
A process is provided for preparing a compound of the following general formula (I) wherein R1 represents hydrogen, an alkyl group of 1 to 12 carbon atoms, an aryl group of 6 to 12 carbon atoms or an aralkyl group of 7 to 12 carbon atoms...  
WO/2012/017166A2
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/010172A1
The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). Formula (I) and (II). Furthermore, the invention relates to intermediates useful for the synthesis of ingenol-3-angelate (I) from ingenol (II...  

Matches 201 - 250 out of 7,670